Industry Insights

  1. Trends In Raw Materials Characterization In Bioprocessing 5/3/2022

    Find out more about the current trends shaping the future of raw materials characterization in bioprocessing, and how you can take advantage of them.

  2. Microbial Biomanufacturing: Where We've Been And Where We Are Going 7/30/2024

    Learn more about the cutting-edge technologies driving the shift to microbial expression and how the right outsourcing partner can help you leverage the benefits of these innovative therapeutics.

  3. How Pharma 4.0 Can Unlock The Full Potential Of External Manufacturing 2/27/2024

    To address today's challenges and other headwinds, pharma/biotech organizations and CMO/CDMO partners need to re-evaluate and improve externalized operating models. Consider further investing in digitalizing collaboration processes as part of operational excellence and digital transformation road map efforts. 

  4. Peptide Synthesis: New Market Research 11/3/2024

    Peptide synthesis is used to create new vaccines, medications, and enzymes. This article provides an overview of solid phase and liquid phase synthesis as well as new market research.

  5. A Payday For Payloads: The Transactional Landscape Of ADCs 2/16/2023

    In the last five years, ADCs deals have netted some of the biggest payouts in oncology drug development. The transactions signal excitement for the evolving modality's long-term exclusivity potential and robust targeting capabilities.

  6. Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight 7/23/2024

    By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

  7. The Case For Optimism In The U.S. Biosimilar Market 7/28/2020

    In the U.S., it is estimated that biosimilars can save the healthcare system approximately $150 billion over the next five to 10 years. In this op-ed, Amgen's Chad Pettit shares why the U.S. has cause to be optimistic about the competition emerging in the U.S. 

  8. Cost And Scalability Key Drivers Of Expanded Gene Therapy Access 5/16/2025

    Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

  9. Aseptic Environmental Monitoring For Vaccine Manufacturing 4/23/2021

    To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

  10. Managing Contamination Risks In The Pharmaceutical And Medical Device Industries Using Relational Risk Analysis 2/18/2025

    Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.